Clinical experience with the single-plate Molteno implant in complicated glaucomas.
Clinical experience with the single-plate Molteno implant in complicated glaucomas.
复制标题
单板 Molteno 植入物治疗复杂性青光眼的临床经验。
DOI：
10.1016/s0161-6420(88)33029-0
复制
发表时间：
1988
期刊：
影响因子：
13.7
通讯作者：
Barlow,WE
中科院分区：
文献类型：
--
作者：
Minckler,DS;Heuer,DK;Hasty,B;Baerveldt,G;Cutting,RC;Barlow,WE
Ninety patients with medically uncontrollable glaucomas and poor surgical prognoses received single-plate Molteno implants (Optomat Supplies, Dunedin, New Zealand) without postoperative adjunctive systemic antifibrosis therapy. Eleven patients had insufficient follow-up for assessment of intraocular pressure (IOP) or visual acuity outcome. The initial Molteno implant procedures in the remaining 79 patients were successful (IOP ≤ 21 mmHg with at least 6 months' follow-up) in 26 (63%) of the 41 patients older than 12 years of age with non-neovascular glaucomas in aphakia/pseudophakia; 7 (70%) of the 10 patients older than 12 years of age with non-neovascular glaucomas in phakic eyes after failed filtering surgery; 7 (47%) of the 15 patients with neovascular glaucomas; and 7 (54%) of the 13 patients younger than 13 years of age with non-neovascular glaucomas. The visual acuities remained within one line of their preoperative levels or improved in 31 (76%) of the 41 aphakic or pseudophakic eyes with non-neovascular glaucomas; 3 (30%) of the 10 phakic eyes with non-neovascular glaucomas after failed filtering surgery; 10 (67%) of the 15 eyes with neovascular glaucomas; and 9 (100%) of the 9 eyes with non-neovascular glaucomas in patients younger than 13 years of age on whom Snellen acuity was available. Complications on all 90 patients included postoperative choroidal hemorrhage (8%), cataract (7%), tube block (6%), corneal graft decompensation (4%), erosion of the tube through host scleral flap and conjunctiva (3%), phthisis bulbi (2%), hypotony (2%), kissing serous choroidal effusion (2%), traction retinal detachment (RD) (2%), corneal edema (1%), corneal epitheliopathy (1%), tube retraction (1%), tube to cornea touch (1%), flat anterior chamber (1%), pupillary membrane (1%), recurrent vitreous hemorrhages (1%), and RD associated with retinal dialysis (1%).
